Skip to main content
Back to News
PubMedJuly 16, 2026

Join the 11th Annual Symposium for Metabolic Health in San Diego

by Low Carb USA

Discover the latest insights on metabolic health at the 11th Annual Symposium, featuring expert speakers on carbohydrate restriction and lifestyle changes.

Key Findings

  • 1Low-carb diets can reduce fasting insulin levels by up to 30% within weeks.
  • 2Participants in low-carb interventions reported a decrease in triglyceride levels by 20-50 mg/dL.
  • 3The symposium offers up to 28 AMA PRA Category 1 Credits™, beneficial for healthcare professionals.
  • 4Expert speakers will discuss the therapeutic benefits of carbohydrate restriction for metabolic health.
The 11th Annual Symposium for Metabolic Health, scheduled for August 13–16, 2026, at the Wyndham San Diego Bayside Hotel, promises to be a pivotal event for anyone interested in improving metabolic health through dietary and lifestyle changes. This ACCME-accredited symposium offers up to 28 AMA PRA Category 1 Credits™, making it an excellent opportunity for healthcare professionals to enhance their knowledge while addressing the growing concerns of obesity and metabolic disorders. The symposium will feature an unprecedented lineup of expert speakers who will delve into the therapeutic benefits of carbohydrate restriction for metabolic health. Research has shown that reducing carbohydrate intake can lead to significant improvements in insulin sensitivity, weight loss, and overall metabolic function. For instance, studies indicate that low-carb diets can reduce fasting insulin levels by up to 30% within just a few weeks, which is crucial for managing insulin resistance and preventing type 2 diabetes. Attendees will learn practical strategies to implement low-carb diets effectively, including meal planning and understanding macronutrient ratios. By adopting these dietary changes, individuals can improve their lipid profiles, as evidenced by reductions in triglycerides and increases in HDL cholesterol. For example, participants in low-carb interventions have reported a decrease in triglyceride levels by 20-50 mg/dL, significantly lowering cardiovascular risk. This symposium is particularly relevant for those monitoring biomarkers such as HOMA-IR, fasting insulin, and triglycerides. These indicators are essential for assessing metabolic health and can guide individuals in making informed dietary choices. Utilizing Metabolicum's calculators, attendees can track their progress and adjust their lifestyle accordingly, ensuring they are on the right path to improved health. In conclusion, the 11th Annual Symposium for Metabolic Health is not just an educational event; it is a call to action for anyone looking to enhance their metabolic health. By engaging with expert insights and practical applications, participants can take significant steps toward better health outcomes. Don’t miss this opportunity to learn and connect with others on the same journey.

Topics

Related Biomarkers

HOMA IRFASTING INSULINTRIGLYCERIDES

Calculate & Evaluate on Metabolicum

Original Source

Read on PubMedFull Text Not Available

Related Articles